Janssen Korea, Ltd.

Clinical trials sponsored by Janssen Korea, Ltd., explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A subsidiary of Johnson & Johnson, involved in pharmaceutical sales and research in Korea.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Bladder cancer surgery: what happens after the bladder is removed? Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Completed 1

Big data study tracks Kids' bowel disease in korea

Knowledge-focused Recruiting now

This study uses health insurance claims data from Korea to count how many children under 18 have Crohn's disease or ulcerative colitis, and how their treatment changes as they grow. Researchers will look at patterns of medication use, hospital visits, and costs over several years…

Sponsor: Janssen Korea, Ltd., Korea • Aim: Knowledge-focused

Last updated Aug 30, 2026 00:00 UTC

Janssen Korea, Ltd.

Upcoming readouts

Big data study tracks Kids' bowel disease in korea